The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia

por Jimbu, Laura, Mesaros, Oana, Neaga, Alexandra, Nanut, Ana Maria, Tomuleasa, Ciprian, Dima, Delia, Bocsan, Corina, Zdrenghea, Mihnea
Publicado 2021